Trade

with

Codexis Inc
(NASDAQ: CDXS)
AdChoices
2.32
-0.06
-2.52%
After Hours :
-
-
-

Open

2.37

Previous Close

2.38

Volume (Avg)

66.52k (151.66k)

Day's Range

2.30-2.40

52Wk Range

1.24-3.30

Market Cap.

93.14M

Dividend Rate ( Yield )

-

Beta

1.60

Shares Outstanding

39.13M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 31.92M

    • Net Income

    • -41.30M

    • Market Cap.

    • 93.14M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -125.15

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.60

    • Forward P/E

    • -

    • Price/Sales

    • 3.27

    • Price/Book Value

    • 3.10

    • Price/Cash flow

    • -4.66

      • EBITDA

      • -31.06M

      • Return on Capital %

      • -56.15

      • Return on Equity %

      • -76.42

      • Return on Assets %

      • -56.15

      • Book Value/Share

      • 0.75

      • Shares Outstanding

      • 39.13M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -5.80

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -8.76

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 63.47

            • 82.75

            • Pre-Tax Margin

            • -127.28

            • 39.38

            • Net Profit Margin

            • -125.15

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 67.90

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -41.90

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -41.90

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 2.49

              • 2.92

              • Quick Ratio

              • 2.13

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 1.54

              • 2.21

              • Book Value/Share

              • 0.75

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -2.58

                • 217.39

                • P/E Ratio 5-Year High

                • -16.86

                • 634.30

                • P/E Ratio 5-Year Low

                • -1.40

                • 124.82

                • Price/Sales Ratio

                • 3.23

                • 9.52

                • Price/Book Value

                • 3.06

                • 8.61

                • Price/Cash Flow Ratio

                • -4.66

                • 50.51

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -76.42

                    (-)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • -56.15

                    (-24.10)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • -76.42

                    (-)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • -

                  • 117.08k

                  • Inventory Turnover

                  • 6.01

                  • 1.48

                  • Asset Turnover

                  • 0.45

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -41.15M
                  Operating Margin
                  -128.90
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -4.66
                  Ownership

                  Institutional Ownership

                  58.17%

                  Top 10 Institutions

                  53.01%

                  Mutual Fund Ownership

                  5.60%

                  Float

                  74.44%

                  5% / Insider Ownership

                  7.01%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • FCP OP MEDICAL BioHealthTrends

                  •  

                    446,334

                  • 0.00

                  • 1.15

                  • Vanguard Total Stock Mkt Idx

                  •  

                    391,190

                  • 0.00

                  • 1.00

                  • Vanguard Extended Market Index Fund

                  •  

                    239,986

                  • 0.00

                  • 0.61

                  • APO Medical Opportunities

                  •  

                    216,333

                  • -0.48

                  • 0.50

                  • Bridgeway Ultra Small Company Market

                  •  

                    150,500

                  • 0.00

                  • 0.39

                  • iShares Micro-Cap

                  •  

                    88,224

                  • 0.00

                  • 0.23

                  • AMG Managers Essex Small/Micro Cap Gr Fd

                  •  

                    80,761

                  • -5.34

                  • 0.21

                  • PHARMA/wHEALTH

                  •  

                    75,876

                  • 0.00

                  • 0.20

                  • Fidelity Spartan® Extended Mkt Indx Fd

                  •  

                    66,590

                  • 0.00

                  • 0.17

                  • Vanguard Instl Total Stock Market Index

                  •  

                    54,399

                  • 0.00

                  • 0.14

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Nantahala Capital Management, LLC

                  •  

                    3,154,920

                  • +6.05%

                  • 8.12

                  • EDB INVESTMENTS PTE LTD

                  •  

                    2,958,522

                  • -6.33%

                  • 7.71

                  • Third Security, LLC

                  •  

                    1,674,699

                  • -7.22%

                  • 4.31

                  • BlackRock Fund Advisors

                  •  

                    1,074,608

                  • 0.00%

                  • 2.77

                  • 683 Capital Management LLC

                  •  

                    1,062,500

                  • 0.00%

                  • 2.73

                  • Opaleye Management Inc

                  •  

                    820,000

                  • +17.43%

                  • 2.11

                  • Vanguard Group, Inc.

                  •  

                    637,005

                  • 0.00%

                  • 1.64

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  Distressed

                  Style

                  Small Value

                  Codexis, Inc. was incorporated in Delaware in January 2002. The Company is a developer of proprietary biocatalysts, which are enzymes or microbes that initiate or accelerate chemical reactions. Its proven technologies enable scale-up...more and implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable process development, from research to manufacturing. The Company has commercialized its technology and products in the pharmaceuticals market. The pharmaceutical customers, which include several pharmaceutical companies, use its technology, products and services in their manufacturing process development, including in the production of some of the world's bestselling and fastest growing drugs. It has recently started to use its technology to develop biocatalysts...more for use in the fine chemicals markets. The fine chemicals market is similar to its pharmaceutical business and consists of several large market segments, including food, animal feed, polymers, flavors and fragrances and agricultural chemicals, and so it is a natural fit for its technology. Its technology is also currently being used by a customer to manufacture butadiene, an intermediate for the manufacture of polymers. The Company’s pharmaceutical products include enzymes, pharmaceutical intermediates, active pharmaceutical ingredients (API), and Codex Biocatalyst Kits and Panels. It markets and sells enzymes, development services and Codex Biocatalyst Kits and Panels screening tools that enable novel manufacturing processes for APIs and their precursor pharmaceutical intermediates. It also markets and sells pharmaceutical intermediates that are manufactured using its custom enzymes. The registered and pending United States and foreign trademarks include Codexis, Codex, CodeEvolver, CodeXporter, CodeXol, CodeXyme, Powered by CodeEvolver®, We Are Biocatalysis, Mosaic, Sage, Microcyp, Hit from a Kit, Prosar and a Codexis and design mark. The competitors include Solvias Inc. and Takasago International Corporation who use metal-based chemical reactions for their pharmaceutical products, industrial enzyme companies, such as Novozymes, as well as subsidiaries of larger pharmaceutical companies, such as DSM, Cambrex Corporation and Almac Group Ltd. There is also competition in the customized and optimized enzyme area from several small European companies, such as BRAIN AG, C-LEcta GmbH and evocatal GmbH. The Company’s operations comply with environmental laws and regulations.lessless

                  Key People

                  John J. Nicols

                  CEO/Director/President

                  Thomas R. Baruch

                  Chairman of the Board/Director

                  Gordon Sangster

                  CFO/Senior VP

                  Mr. Douglas T. Sheehy

                  Chief Administrative Officer/Executive VP/General Counsel/Secretary

                  Mr. Dennis P. Wolf

                  Director

                  • Codexis Inc

                  • 200 Penobscot Drive

                  • Redwood City, CA 94063

                  • USA.Map

                  • Phone: +1 650 421-8100

                  • Fax: -

                  • codexis.com

                  Incorporated

                  2002

                  Employees

                  125

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: